TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ABEO

Abeona Therapeutics Inc

Healthcare · Biotechnology

5.50$ -5.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Abeona Therapeutics Inc (ABEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 180 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABEO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
66 64 75 134 121 109 99 246 231 220 198 180
57 56 67 126 113 101 88 232 216 205 183 165
4.7 14 18 34 16 23 16 164 83 78 61 56
54 52 62 123 110 98 84 226 207 191 168 147
2.2 2.4 2.2 1.6 1.6 1.7 1.6 1.6 1.6 6.7 6.7 9.9
0.3 – – – – 0.0 – 2.7 4.9 5.5 6.1 5.9
8.7 – – – – – – – – – – –
44 49 84 61 75 65 58 83 60 60 54 51
8.4 13 12 17 18 17 18 35 22 30 31 25
1.6 1.0 1.0 4.0 5.5 6.7 8.8 6.1 9.0 13 15 15
2.6 1.9 3.4 3.1 2.8 3.4 5.0 7.3 5.9 7.9 4.1 3.0
– – 18 16 14 13 11 14 11 7.8 4.8 1.7
22 15 -8.9 73 46 44 41 164 171 159 145 128
-733 -750 -781 -774 -804 -813 -825 -716 -722 -742 -759 -779
25 26 27 51 48 41 50 67 54 66 57 57

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?